• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在药物与口服避孕药的相互作用研究中评估排卵风险。

Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives.

作者信息

de la Rey N, Schall R, Luus H G, Meyer B H, Müller F O

机构信息

FARMOVS Institute for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, Republic of South Africa.

出版信息

Int J Clin Pharmacol Ther Toxicol. 1993 Sep;31(9):435-9.

PMID:8225692
Abstract

When certain drugs are taken concomitantly with an oral contraceptive, the efficacy of the contraceptive may be obtunded, and pregnancy may ensue. Since the function of oral contraceptives is to suppress ovulation, the risk of ovulation is an important parameter in clinical studies investigating interactions between drugs and oral contraceptives. The purpose of this paper is to compare a crossover design, and a new study design used for assessing a possible interaction between a drug and an oral contraceptive, and to discuss the statistical issues involved in the planning and evaluation of the results of such studies.

摘要

当某些药物与口服避孕药同时服用时,避孕药的功效可能会减弱,进而可能导致怀孕。由于口服避孕药的作用是抑制排卵,排卵风险是研究药物与口服避孕药之间相互作用的临床研究中的一个重要参数。本文的目的是比较一种交叉设计和一种用于评估药物与口服避孕药之间可能存在的相互作用的新研究设计,并讨论此类研究在规划和结果评估中涉及的统计学问题。

相似文献

1
Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives.在药物与口服避孕药的相互作用研究中评估排卵风险。
Int J Clin Pharmacol Ther Toxicol. 1993 Sep;31(9):435-9.
2
A randomized trial on the impact of starting day on ovarian follicular activity in very low dose oral contraceptive pills users.一项关于开始服药日对极低剂量口服避孕药使用者卵巢卵泡活性影响的随机试验。
J Med Assoc Thai. 2003 May;86(5):442-8.
3
Oral contraceptive update: new agents and regimens.
J Fam Pract. 2004 Jul;Suppl:S5-12.
4
Use and misuse of the term potency with respect to oral contraceptives.关于口服避孕药,“效力”一词的使用与误用
J Reprod Med. 1986 Jun;31(6 Suppl):533-9.
5
[Oral contraceptives in dermatology].
Actas Dermosifiliogr. 2009 Jul-Aug;100(6):445-55.
6
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].[低剂量口服避孕药的个体化。口服避孕药的药理学原理及实际应用指征]
Minerva Ginecol. 2007 Aug;59(4):415-25.
7
The menstrual cycle after withdrawal of oral contraceptives with particular reference to return of ovulation.
Mater Med Pol. 1975 Apr-Jun;7(2):126-32.
8
Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years.35岁以上女性使用经皮避孕贴片与口服避孕药的周期控制及副作用比较。
J Med Assoc Thai. 2007 Sep;90(9):1715-9.
9
[Safety, efficacy and control of the menstrual cycle by a monophasic oral contraceptive containing 75 mcg of gestodene and 30 mcg of ethynyl estradiol].[含75微克孕二烯酮和30微克乙炔雌二醇的单相口服避孕药对月经周期的安全性、有效性及调控]
Ginecol Obstet Mex. 1993 Oct;61:299-303.
10
The impact of antiepileptic drug therapy on steroidal contraceptive efficacy.
Epilepsy Behav. 2006 Aug;9(1):31-9. doi: 10.1016/j.yebeh.2006.05.002.